External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience CNS 2026
Roche and Genentech at

CNS 2026

October 14 - October 17
Montreal, Canada
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
04:45 PM
Duration 15mins Montreal, Canada
Efficacy and Safety of Ocrelizumab Compared With Fingolimod in Pediatric-Onset Relapsing-Remitting MS: Results of the Phase III OPERETTA 2 Study
Fabien Bakdache, Brenda Banwell, Katarzyna Kotulska, Kevin Rostásy, Kumaran Deiva, Henry Sato, Massimo Filippi, Tanuja Chitnis, Maria Pia Sormani, Lauren Krupp, Amit Bar-Or, Joanna Evershed, Bouchra El Azzouzi, Qing Wang, Chien-Ju Lin, Alexandra Hogea, Hans-Martin Schneble, Corinne Manlius, Emmanuelle Waubant
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.